MU
Michael Ulz Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
62.5%
Neutral
37.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $81 |
27%
upside
| 3 | – |
–
| 7 Jan ‘26 11 days ago |
|
|
|
Overweight
Maintained
| $50 |
199%
upside
| 1 | -25% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $95 |
4%
upside
| 1 | +12% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $25 |
199%
upside
| 1 | +144% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $94 |
23%
upside
| 1 | +16% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $102 |
201%
upside
| 1 | +15% |
0
%
| 23 Oct ‘25 2 months ago |
|